iCad jumps on bullish SA Pro article

|By:, SA News Editor

iCAD (ICAD +5.7%) shares jump on double 3-month average volume after SA Pro's Inflection Point Investing says (embargoed until 9:30 ET tomorrow) that the image analysis / radiation therapy device maker has "multi-bagger potential" as it approaches a "pivotal inflection point."

The author observes, "iCAD's shares have a $75 million market capitalization. For a company with a disruptive cancer technology platform, already showing two years of very strong year-over-year growth, and a CAD software business poised to re-boot, we believe iCAD could follow a similar trajectory seen in shares of both Mazor Robotics and Novadaq Technologies."